Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 116
  2. 117
  3. 118
  4. 119
  5. 120
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Adalimumab Biosimilar -­ HRP Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH4001HRP-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Alemtuzumab Biosimilar -­ Biotin Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH4002B-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Alemtuzumab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, IHC CHO cells ICH4002D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Alemtuzumab Biosimilar -­ HRP Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH4002HRP-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Bevacizumab Biosimilar -­ Biotin Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH4003B-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Bevacizumab Biosimilar -­ HRP Research Grade Produkt-Datenblatt downloaden Biosimilars Other ICH4003HRP-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Cetuximab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, IHC CHO cells ICH4004D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Nivolumab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, IHC CHO cells ICH4009D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Rituximab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, IHC CHO cells ICH4011D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Trastuzumab Biosimilar -­ Biotin Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, ELISA ICH4013B-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Trastuzumab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, IHC CHO cells ICH4013D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Trastuzumab Biosimilar -­ HRP Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, ELISA ICH4013HRP-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Atezolizumab Biosimilar -­ Dylight488 Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FC, IHC CHO cells ICH4018D488-0.1mg

IchorBio 		100 ug Anmelden
Vergleichen
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4003UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4003UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4003UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4003UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4003UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4003UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4004UL-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4004UL-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4004UL-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4004UL-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4004UL-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Cetuximab Biosimilar -­ Ultra Low Endotoxin Produkt-Datenblatt downloaden Biosimilars Hu ICH4004UL-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Name Preis
Adalimumab Biosimilar -­ HRP Research Grade Anmelden Adalimumab Biosimilar - HRP Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Alemtuzumab Biosimilar -­ Biotin Research Grade Anmelden Alemtuzumab Biosimilar - Biotin Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Alemtuzumab Biosimilar -­ Dylight488 Research Grade Anmelden Alemtuzumab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, IHC
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Alemtuzumab Biosimilar -­ HRP Research Grade Anmelden Alemtuzumab Biosimilar - HRP Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Bevacizumab Biosimilar -­ Biotin Research Grade Anmelden Bevacizumab Biosimilar - Biotin Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Bevacizumab Biosimilar -­ HRP Research Grade Anmelden Bevacizumab Biosimilar - HRP Research Grade
Typ Biosimilars
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 ug
Lieferbar
Cetuximab Biosimilar -­ Dylight488 Research Grade Anmelden Cetuximab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, IHC
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Nivolumab Biosimilar -­ Dylight488 Research Grade Anmelden Nivolumab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, IHC
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Rituximab Biosimilar -­ Dylight488 Research Grade Anmelden Rituximab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, IHC
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Trastuzumab Biosimilar -­ Biotin Research Grade Anmelden Trastuzumab Biosimilar - Biotin Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, ELISA
Host
ArtNr.
Menge 100 ug
Lieferbar
Trastuzumab Biosimilar -­ Dylight488 Research Grade Anmelden Trastuzumab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, IHC
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Trastuzumab Biosimilar -­ HRP Research Grade Anmelden Trastuzumab Biosimilar - HRP Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, ELISA
Host
ArtNr.
Menge 100 ug
Lieferbar
Atezolizumab Biosimilar -­ Dylight488 Research Grade Anmelden Atezolizumab Biosimilar - Dylight488 Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FC, IHC
Host CHO cells
ArtNr.
Menge 100 ug
Lieferbar
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Bevacizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Bevacizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 10 mg
Lieferbar
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Bevacizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Bevacizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 20 mg
Lieferbar
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Bevacizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 50 mg
Lieferbar
Bevacizumab Biosimilar -­ Ultra Low Endotoxin Anmelden Bevacizumab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 5 mg
Lieferbar
Cetuximab Biosimilar -­ Ultra Low Endotoxin Anmelden Cetuximab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Cetuximab Biosimilar -­ Ultra Low Endotoxin Anmelden Cetuximab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 10 mg
Lieferbar
Cetuximab Biosimilar -­ Ultra Low Endotoxin Anmelden Cetuximab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Cetuximab Biosimilar -­ Ultra Low Endotoxin Anmelden Cetuximab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 20 mg
Lieferbar
Cetuximab Biosimilar -­ Ultra Low Endotoxin Anmelden Cetuximab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 50 mg
Lieferbar
Cetuximab Biosimilar -­ Ultra Low Endotoxin Anmelden Cetuximab Biosimilar - Ultra Low Endotoxin
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 5 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 116
  2. 117
  3. 118
  4. 119
  5. 120
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top